As the middlemen between drug companies and insurers, PBMs are shoo-ins as the villains behind high drug prices. But they do play a useful role in the health marketplace.
- Wexler Professor of Management, Economics and Public Policy, Boston University
Contact James for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Article Feed
- Joined
